NASH

Mr RICHARD GUILLAUME IS APPOINTED TO THE DIAFIR BOARD OF DIRECTORS

2019-04-08 // 0 Comments

RENNES, FRANCE, 2019-Apr-08 — /EPR Network/ — DIAFIR, a medical technology company focused on the development, manufacture and sale of innovative diagnostic solutions in nonalcoholic steatohepatitis [read full press release…]

Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Projections, Opportunities & Competitive Scenario Recorded until 2027

2018-10-30 // 0 Comments

Albany, US, 2018-Oct-30 — /EPR Network/ —The global market status for Non-Alcoholic Steatohepatitis is precisely examined through a smart research report added to the broad [read full press release…]

Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Therapeutics Assessment Focusing on Market Outlook, 2018

2018-05-09 // 0 Comments

Alabny, US, 2018-May-09 — /EPR Network/ —A new research report titled, “Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Drug Development Pipeline Review, [read full press release…]